Sterilizing immunity after vaccination is desirable to prevent the spread of infection from
vaccinees, which can be especially dangerous in hospital settings while managing frail …

Background There is significant risk of complications and vulnerability to severe COVID‐19
disease in pregnancy, yet hesitancy exists around COVID‐19 vaccination during pregnancy …

Introduction The concern of undergoing vaccination during pregnancy and lactation, in
absence of data on safety and efficacy in these target populations, is subject of ongoing …

BNT162b2 is a vaccine developed to prevent coronavirus disease 2019 (COVID-19).
BNT162b2 is a lipid nanoparticle formulated nucleoside-modified messenger RNA (mRNA) …

Lactating women can produce protective antibodies in their milk after vaccination, which has
informed antenatal vaccination programs for diseases such as influenza and pertussis …

Background Immunological protection via breastfeeding is well known. The immunological
profile of human milk changes during lactation. No clinical trials have been conducted in …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are
being administered around the world; however, lactating women were excluded from SARS …

RNA-based vaccines against SARS-CoV-2 have proven critical to limiting COVID-19
disease severity and spread. Cellular mechanisms driving antigen-specific responses to …

Objectives The availability of new vaccines against COVID-19 urges for guidance about
vaccination during lactation. We aimed to review the literature to get an insight into the …

Background Breast milk is a vehicle to transfer protective antibodies from the lactating
mother to the neonate. After SARS-CoV-2 infection, virus-specific IgA and IgG have been …